Form Type: 4

SEC EDGAR Link
Accession Number:0001479290-21-000099
Date:2021-04-15
Issuer: REVANCE THERAPEUTICS, INC. (RVNC)
Original Submission Date:

Reporting Person:

SJUTS DUSTIN S
C/O REVANCE THERAPEUTICS, INC
1222 DEMONBREUN STREET, SUITE 1001 NASHVILLE, TN 37203

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-04-15 F 411 d $28.16 65,098 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents the number of shares withheld by and surrendered to the issuer on april 15, 2021, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock award ("rsa") for 5,000 shares. the rsa vests in four equal annual installments from april 15, 2018, subject to mr. sjuts' continuous service (as defined in the issuer's 2014 equity incentive plan) on each vesting date.
WhaleWisdom Logo

Elevate your investments